ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.1
  1. ホーム
  2. /化合物

Tyramine

HCID 5610
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
51-67-2
標準SMILES
NCCc1ccc(O)cc1
InChIKey
DZGWFCGJZKJUFP-UHFFFAOYSA-N
分子式
C8H11NO
平均分子量
137.18 g/mol
単同位体質量
137.08406397

概要

Tyramine is a primary amino compound obtained by formal decarboxylation of the amino acid tyrosine. It has a role as a neurotransmitter, an EC 3.1.1.8 (cholinesterase) inhibitor, a mouse metabolite, an Escherichia coli metabolite and a human metabolite. It is a monoamine molecular messenger, a member of tyramines and a primary amino compound. It is a conjugate base of a tyraminium.

名称と識別子

優先名称
Tyramine
IUPAC
4-(2-aminoethyl)phenol
英語名
51-67-2
分子量
0

名称と別名

tyramine51-67-24-(2-Aminoethyl)phenolUteramine2-(4-Hydroxyphenyl)ethylamineTyrosamineTocosine4-HydroxyphenethylamineSystogeneTyramin4-HydroxyphenylethylaminePhenol, 4-(2-aminoethyl)-
名称をさらに表示
p-(2-Aminoethyl)phenolp-HydroxyphenethylamineTenosin-wirkstoffp-Hydroxyphenylethylamine2-(p-Hydroxyphenyl)ethylaminep-beta-AminoethylphenolBenzeneethanamine, 4-hydroxy-beta-Hydroxyphenylethylamine

データベース識別子

CAS
51-67-2
PubChem CID
5610
DTXSID
DTXSID2043874
ChEMBL
CHEMBL11608
ChEBI
CHEBI:15760
UNII
X8ZC7V0OX3
EC Number
200-115-8
Nikkaji
J4.123H

物性

構造計算による物性補完中

XLogP
1.1
極性表面積
46.3 Ų
水素結合供与体数
2
水素結合受容体数
2
回転可能結合数
2
重原子数
10
形式電荷
0
複雑度
87.3

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LogP · 2 件

Log Kow = 0.72

-0.24

Food AdditivesFLAVORING AGENT OR ADJUVANT -> FDA Substance added to food
Flavoring AgentsEU Flavoring substances
Color/Form · 2 件

CRYSTALS FROM BENZENE OR ALCOHOL

PLATES OR NEEDLES FROM BENZENE, NEEDLES FROM WATER

Solubility · 6 件

SOL IN WATER /TYRAMINE HYDROCHLORIDE/

1 G DISSOLVES IN 10 ML BOILING ALCOHOL

SPARINGLY SOL IN BENZENE, XYLENE

Slightly soluble in water, benzene; soluble in ethanol, xylene

Water solubility = 10.4E+3 mg/L @ 15 °C

10.4 mg/mL at 15 °C

Boiling Point166 °C @ 2 MM HG
Melting Point · 3 件

164-165 °C

MP: 269 °C /TYRAMINE HYDROCHLORIDE/

164 - 165 °C

Physical Description · 2 件

Solid

Colourless to yellow solid; Sweet meaty aroma

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 65.9% (91 of 138) of all reports.

Warning

H315 (32.6%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 138 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 4 件

Chemical: Phenol, 4-(2-aminoethyl)-

Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)

Status: Active Update: 05-01-2016 https://echa.europa.eu/registration-dossier/-/registered-dossier/16729

Phenol, 4-(2-aminoethyl)-: Does not have an individual approval but may be used under an appropriate group standard

Special ReportsThe monoamine oxidase inhibitor tyramine reaction.[Brown C et al; J Clin Pharmacol 29 (6): 529-32 (1989)]
Hazard Classes and CategoriesSkin Irrit. 2 (32.6%)

安全と保護具

Disposal Methods · 1 件

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

毒性情報

化学と産業

薬理情報

Mechanism of Action... Findings indicate that tyramine acts presynaptically to cause a release of endogenous norepinephrine from the nerve, which in turn acts on postjunctional receptors.
Metabolism/Metabolites · 6 件

THERE HAVE BEEN SEVERAL...METABOLIC STUDIES OF TYRAMINE IN MAMMALS, & TRACERS HAVE BEEN USED. ...SMALL AMT OF P-HYDROXYMANDELIC ACID, VANILMANDELIC ACID, & HOMOVANILLIC ACID /HAVE BEEN INDENTIFIED/.

WHEN TYRAMINE...WAS INJECTED INTO RATS, MAJOR URINARY METABOLITE WAS FREE P-HYDROXYPHENYLACETIC ACID...

...TYRAMINE...PRESENT IN CHEESE AND IN YEAST EXTRACT...IS NORMALLY DETOXICATED BY MONOAMINE OXIDASE, PRESENT IN INTESTINE AND LIVER, TO YIELD PARA-HYDROXYPHENYLETHANOL, PARA-HYDROXYPHENYLACETIC ACID AND ITS GLYCINE CONJUGATE, PARA-HYDROXYPHENACETURIC ACID, AND...N-ACETYLTYRAMINE.

WHEN HUMAN/S/...TREATED WITH (14)C-TYRAMINE.../URINARY METABOLITE/ P-HYDROXYPHENYLACETALDEHYDE...CONTRIBUTED LESS THAN 0.5%.

For more Metabolism/Metabolites (Complete) data for TYRAMINE (6 total), please visit the HSDB record page.

Tyramine has known human metabolites that include Dopamine and Tyramine glucuronide.

MeSH Pharmacological Classification · 2 件

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.

Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.

Absorption, Distribution and Excretion · 4 件

96% OF (14)C WAS EXCRETED IN 24-HR URINE OF RATS GIVEN IP DOSE OF...(14)C TYRAMINE. 67% WAS EXCRETED IN 3 HR, BUT THIS AMT WAS MARKEDLY REDUCED IF RATS WERE PRETREATED WITH MONOAMINE OXIDASE INHIBITOR. /HUMANS/...EXCRETED 58% OF (14)C IN 24-HR URINE FOLLOWING IV DOSE...

WHEN TYRAMINE...WAS INJECTED INTO RATS, MAJOR URINARY METABOLITE WAS FREE P-HYDROXYPHENYLACETIC ACID...(77% OF THAT PROPORTION OF DOSE EXCRETED IN URINE)...

関連反応

339 件
反応記録を作成
HRID 1540 の反応式
HRID 1540反応物としてuspto-grants-1998_03
HRID 2681 の反応式
HRID 2681反応物としてuspto-grants-1998_03
HRID 11730 の反応式
HRID 11730反応物としてuspto-grants-2006_08
HRID 14703 の反応式
HRID 14703反応物としてuspto-grants-2010_06
HRID 14734 の反応式
HRID 14734反応物としてuspto-grants-2010_06
HRID 14743 の反応式
HRID 14743反応物としてuspto-grants-2010_06
HRID 14744 の反応式
HRID 14744反応物としてuspto-grants-2010_06
HRID 14746 の反応式
HRID 14746反応物としてuspto-grants-2010_06
前へ1 / 43 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
Collision Cross Section · 3 件

123.43 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]

129.74 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

138.4 Ų [M+Na]+

Other Experimental PropertiesCRYSTALS FROM ALCOHOL + ETHER /TYRAMINE HYDROCHLORIDE/

物理化学的性質

融点
164 · 164-165 °C
沸点
166 °C · 166 °C(Press: 2 Torr)
比重(密度)
1.103 · 1.103±0.06 g/cm3(Predicted)
酸解離定数(Pka)
9.51 · 9.51±0.26(Predicted)
Treatment · 1 件

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

Interactions · 5 件

ANTIBACTERIAL ACTION OF FURAZOLIDONE IS ACCOMPANIED BY PROGRESSIVE & GENERALIZED INHIBITION OF MONOAMINE OXIDASE... TYRAMINE HAS...BEEN REPORTED TO INTERACT WITH FURAZOLIDONE...

PHENYLPROPANOLAMINE & OTHER INDIRECT-ACTING SYMPATHOMIMETIC AMINES (EG, TYRAMINE) PRODUCE HYPERTENSIVE CRISIS & RELATED SYMPTOMS IN SOME INDIVIDUALS CURRENTLY RECEIVING OR PREVIOUSLY BEING TREATED WITH TRANYLCYPROMINE OR OTHER MONOAMINE OXIDASE INHIBITORS /SUCH AS ISOCARBOXAZID, PARGYLINE & PHENELZINE/. ...MAY BE FATAL.

ALTHOUGH SELECTIVE MONOAMINE OXIDASE INHIBITOR (-)-DEPRENYL SUBSTANTIALLY INHIBITS TYRAMINE (I)-OXIDIZING ABILITY IN PIG, IV TYRAMINE CHALLENGE AFTER PRETREATMENT WITH THIS DRUG FAILED TO PRODUCE PRESSOR RESPONSE ("CHEESE EFFECT") ASSOC WITH OTHER IRREVERSIBLE MAO INHIBITORS.

PRETREATMENT OF THYROIDECTOMIZED RATS WITH T3 & RESERPINE ABOLISHED TYRAMINE INDUCED HYPOTENSIVE ACTION. PRETREATMENT WITH PHENOXYBENZAMINE INHIBITED ACTION IN INTACT RAT AS WELL, WHEREAS CYPROHEPTADINE INCR ACTION IN THYROIDECTOMIZED RAT BUT NOT IN INTACT RATS

For more Interactions (Complete) data for TYRAMINE (11 total), please visit the HSDB record page.

Health Effects · 1 件

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Certain reproductive effects in fertility, growth, and development for males and females have been linked specifically to organophosphate pesticide exposure. Most of the research on reproductive effects has been conducted on farmers working with pesticides and insecticdes in rural areas. In females menstrual cycle disturbances, longer pregnancies, spontaneous abortions, stillbirths, and some developmental effects in offspring have been linked to organophosphate pesticide exposure. Prenatal exposure has been linked to impaired fetal growth and development. Neurotoxic effects have also been linked to poisoning with OP pesticides causing four neurotoxic effects in humans: cholinergic syndrome, intermediate syndrome, organophosphate-induced delayed polyneuropathy (OPIDP), and chronic organophosphate-induced neuropsychiatric disorder (COPIND). These syndromes result after acute and chronic exposure to OP pesticides.

Toxicity Summary · 1 件

Tyramine is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a halide or thiocyanate), and a terminal oxygen.

Signs and Symptoms · 1 件

Symptoms of low dose exposure include excessive salivation and eye-watering. Acute dose symptoms include severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Hypertension, hypoglycemia, anxiety, headache, tremor and ataxia may also result.

Natural Pollution Sources · 4 件

...TYRAMINE.../ARISES/ FROM MICROBIOLOGICAL DECARBOXYLATION OF CHOLINE, TRYPTOPHAN, TYROSINE, AND OTHER AMINO ACIDS PRESENT IN FOODSTUFF RESIDUES IN INTESTINAL TRACT. ...ALSO FOUND IN PUTREFYING FOODSTUFFS, SUCH AS CHEESE, HIGH GAME & SPOILED FISH, & ETHYLAMINE...

...THE SCLEROTIA /OF ERGOT/ CONTAIN A LARGE NUMBER OF AMINES AND OTHER NITROGENOUS COMPOUNDS, SOME, SUCH AS...TYRAMINE...HAVING PHYSIOLOGICAL ACTIVITY.

...FOODS CONTAINING TYRAMINE.../INCLUDE/ PICKLED HERRING, BEER, WINE (ESP RED WINE), & CHICKEN LIVERS...

BASE FOUND IN MISTLETOE...

Human Toxicity Excerpts · 2 件

Tyramine is a sympathomimetic amine that is without effect when ingested in food because of its rapid biotransformation by monoamine oxidase in the gut and liver. This ... does not occur when monoxidase oxidase is inhibited.

... The role of food additives, tyramine and acetylsalicylic acid, was investigated by double blind placebo controlled challenges in 25 children with severe atopic dermatitis. All children challenged with foods (n = 24), except 1, showed one or more positive reactions to the double blind placebo controlled challenges with foods. Positive reactions presented different combinations of flares of skin symptoms, intestinal symptoms and respiratory systems. Seventeen children (78%) showed a positive challenge to egg, 12% to wheat (50%), eight to milk (33.3%) and eight to soya. Six children underwent double blind placebo controlled challenges with food additives, tyramine and acetylsalicylic acid. All were found to demonstrate positive skin and/or intestinal reactions to at least one of the food additives. Two children reacted to tartrazine, three to sodium benzoate, two to sodium glutamate, two to sodium metabisulfite, four to acetylsalicylic acid and one to tyramine. ... Foods, food additives, tyramine and acetylsalicylic acid can cause positive double blind placebo controlled challenges in children with severe atopic dermatitis.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Tyramine

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Populations at Special Risk... Hypertensive crisis /may result in/ patients receiving monoamine oxidase inhibitors.

安全データ

注意喚起語
警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H315

.../TYRAMINE IS/ POORLY ABSORBED FROM BOWEL, BUT.../IS/ READILY ABSORBED FROM SC INJECTION. .../IT/ MAY BE ABSORBED TO A GREATER OR LESS EXTENT FROM NASAL MUCOSA.

(14)C-LABELED TYRAMINE BOUND TO PLASMA PROTEINS OF RABBITS IN DOSE- & TIME OF INCUBATION-RELATED MANNER. MAX BINDING CAPACITY EST AS 70.2 UG/G. AFFINITY FOR PLASMA PROTEINS MUCH LOWER THAN THAT OF NORADRENALINE.

Tissue LocationsAdipose Tissue
Cellular LocationsCytoplasm
Metabolite PathwaysAlkaptonuria

用途と製造

Uses · 2 件

MEDICATION

Phenethylamines are important precursors of isoquinoline alkaloids and important neuroamines /dopamine and tyramine/.

Methods of ManufacturingDecarboxylation of tyrosine
Use Classification · 2 件

Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes

Flavoring Agents -> JECFA Flavorings Index